3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow

This biotech's growth story is going to start moving faster, and soon. Now's a great time to build up a position in Iovance Biotherapeutics (IOVA -1.28%) with the aim of holding on to its shares for the next few years. Between the recent launch of its innovative cell therapy, strong progress in building up its network of clinics, and a financial situation that looks well-matched to its substantial needs in the near term, this is a biotech that's as well-positioned as stocks in this very risky category tend ...